Bezwada Biomedical, LLC – Trademark Portfolio
Entity Type: 16
Bezwada Biomedical, LLC holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 8 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 5 trademarks are registered and 2 are pending. Notable registered marks include CAPROMAXX, CARBOMAXX, DIOXOMAXX, GLYCOMAXX, and LACTOMAXX. The owner is based in Hillsborough, NJ.
15 Ilene Court, Suite 1
Hillsborough, NJ 08844
Showing of trademarks Trademarks
Trademark Classifications
Bezwada Biomedical, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Bezwada Biomedical, LLC have?
Bezwada Biomedical, LLC has 10 U.S. trademarks filed with the USPTO. Of these, 5 registered, 2 pending, 2 abandoned, 1 cancelled.
What trademark classes does Bezwada Biomedical, LLC file in?
Bezwada Biomedical, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Bezwada Biomedical, LLC's most well-known trademarks?
Bezwada Biomedical, LLC's registered trademark portfolio includes well-known marks such as CAPROMAXX, CARBOMAXX, DIOXOMAXX, GLYCOMAXX, and LACTOMAXX. These are among 5 currently registered trademarks in the portfolio.
What is Bezwada Biomedical, LLC's trademark registration success rate?
Bezwada Biomedical, LLC has a 63% trademark registration rate, with 5 out of 8 resolved applications resulting in successful registration. Currently, 2 applications are pending review.